UPC Analytics
DEEN
Übersicht · Eingereicht: 4. Juli 2025

UPC_CFI_624/2025

ANALYTE SENSOR METHODS

Einstweilige MaßnahmenEinstweilige MaßnahmenThe Hague LDProvisional measuresCase Closed
Dieser Fall zitiert
In den Entscheidungen dieses Falls zitierte Quellen.

UPC-Berufungsgericht · 3

QuelleRechtsfrageBindungskraftAuszug
UPC_CoA_534/2024delivery up to bailiff as proportionate provisional measureÜberzeugendSee also UPC CoA 3.10.2025 UPC_CoA_534/2024, UPC_CoA_683/2024 and UPC_CoA_19/2025), Belkin/Philips
UPC_CoA_683/2024delivery up to bailiff as proportionate provisional measureÜberzeugendSee also UPC CoA 3.10.2025 UPC_CoA_534/2024, UPC_CoA_683/2024 and UPC_CoA_19/2025), Belkin/Philips
UPC_CoA_19/2025delivery up to bailiff as proportionate provisional measureÜberzeugendSee also UPC CoA 3.10.2025 UPC_CoA_534/2024, UPC_CoA_683/2024 and UPC_CoA_19/2025), Belkin/Philips

Verfahrensordnung · 2

QuelleRechtsfrageBindungskraftAuszug
211provisional measuresBindendORDER of the Court of First Instance of the Unified Patent Court Local Division in The Hague issued on 17 October 2025 concerning EP4344633 (R.211 provisional measures)
206.2imminent infringementBindendBy obtaining (and publicly announcing) CE-mark approval for the attacked (implantable) medical devices, providing 'ordering information' and announcing to show-case their products on a trade fair, the Defendants have set the stage to market these products, R. 206.2 lit. c) RoP.

courtName.other · 2

QuelleRechtsfrageBindungskraftAuszug
EU Regulation 608/2013 Art. 2(7)(a)goods suspected of infringing IP right — customs regulationBindendThe requested declaration that the GlucoMen iCan is considered 'goods suspected of infringing an intellectual property right' within the meaning of Article 2(7)(a) of Regulation (EU) No 608/2013, is dismissed.
EU Regulation 2017/745 Art. 5(1)CE marking required for placing medical device on EU market — imminent infringementBindendSince a CE marking is required for placing a medical device in any of the EU member states, obtaining such a CE-mark approval gives an indication of an expected market entry (Art. 5.1 regulation (EU) 2017/745 on medical devices, Art. 33 (1) lit. a UPCA).

EPÜ-Artikel · 1

QuelleRechtsfrageBindungskraftAuszug
Article 33(1) UPCAcompetence — place of infringementBindendArt. 5.1 regulation (EU) 2017/745 on medical devices, Art. 33 (1) lit. a UPCA
Zitiert in
Spätere UPC-Entscheidungen, die diesen Fall zitieren.

Bisher in keiner anderen Entscheidung unseres Korpus zitiert.